1. Neuritogenesis and regeneration in the nervous system: an overview on the problem and on the promoting action of gangliosides;Gorio, A.; Janigro, D.; Zanoni, R.,1984
2. Double blind evaluation of monosialoganglioside (GM) therapy in stroke;Bassi, S.; Albizzati, M.G.; Sbacchi, M.;J Neurosci Res,1984
3. Effects of GM I ganglioside in cerebrovascular disease: a double blind trial in 40 cases;Battistin, I.; Cesari, A.; Galligioni, F.;Eur Neurol,1985
4. Mise au point d'un score neurologique pour l'evaluation clinique des infarctus sylviens;Orgogozo, J.M.; Capildeo, R.; Anagnostou, C.N.;Presse Med,1983
5. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found;Detsky, A.S.; Sackett, D.I.;Arch Intern Med,1985